Myopia is becoming increasingly prevalent, especially among children. With the rise in digital screen time and reduced outdoor activities, more young individuals are developing myopia at an earlier age. While corrective glasses or contact lenses can help with vision, they do not slow myopia’s progression. Early detection and proactive intervention are essential to managing myopia effectively, reducing the risk of long-term complications such as retinal detachment, glaucoma, and myopic maculopathy.
Myopia not only affects a child's ability to see distant objects clearly but also has a significant impact on their learning and overall development. In the classroom, children with uncorrected or progressing myopia may struggle to read the board, recognize faces, or engage in activities that require clear distance vision. This can lead to reduced academic performance, decreased confidence, and frustration with schoolwork. Beyond academics, myopia can also limit participation in sports and outdoor activities, which are essential for physical and social development.
Myopia typically progresses rapidly in childhood and adolescence. Without proper intervention, a child with mild myopia can develop high myopia, increasing the risk of serious eye health concerns later in life. Routine comprehensive eye exams allow optometrists to detect the early signs of myopia and implement strategies to slow its progression. Thanks to advancements in optometry, several evidence-based treatments are available to manage myopia progression in children.
Ortho-K involves specially designed rigid gas-permeable contact lenses that reshape the cornea overnight. By gently flattening the cornea while a child sleeps, these lenses temporarily correct myopia, allowing for clear daytime vision without the need for glasses or daytime contact lenses. Beyond vision correction, Ortho-K has been shown to significantly slow myopia progression, making it a valuable option for active children and those who may struggle with wearing glasses.
Low-dose atropine eye drops have been widely studied for their effectiveness in slowing myopia progression. These medicated drops are typically applied before bedtime and work by relaxing the eye’s focusing mechanisms, reducing the strain that can contribute to myopia progression. Atropine therapy is often combined with other myopia control strategies for optimal results.
MiSight® 1 Day contact lenses are the first FDA-approved daily disposable lenses specifically designed to slow myopia progression in children. These soft contact lenses use innovative optical technology to create peripheral defocus, signaling the eye to slow elongation—the primary cause of myopia. MiSight® lenses offer the convenience of daily wear, making them a practical choice for children and teenagers.
Early intervention in myopia management is key to preserving long-term vision and reducing the risk of serious eye diseases. If your child is showing signs of myopia or has already been diagnosed, now is the time to explore effective treatment options.
At Clarity Advanced Optometry, we specialize in myopia management and offer tailored solutions such as Ortho-K, atropine therapy, and MiSight® 1 Day contact lenses. Please call or text our Myopia Management hotline at 626-268-3069 to schedule a consultation.